To the Editor A recent article in JAMA Internal Medicine,1 later highlighted in a focused review,2 studied outcomes in emergency department chest pain patients with unremarkable electrocardiograms and biomarkers. Results suggest that noninvasive coronary artery disease (CAD) testing leads to more downstream tests and revascularizations compared with no testing, and at 6 months, myocardial infarction (MI) rates are similar for both nonivasive testing and no testing.
Hartlage GR. Noninvasive Testing in Patients With Chest Pain. JAMA Intern Med. 2015;175(10):1727. doi:10.1001/jamainternmed.2015.4152